Phibro Animal Health (NASDAQ:PAHC) Stock Price Up 6.8% on Analyst Upgrade

Phibro Animal Health Co. (NASDAQ:PAHC)’s stock price shot up 6.8% on Monday after Barclays raised their price target on the stock from $20.00 to $22.00. Barclays currently has an underweight rating on the stock. Phibro Animal Health traded as high as $24.21 and last traded at $25.30. 92,480 shares were traded during trading, a decline of 40% from the average session volume of 154,656 shares. The stock had previously closed at $23.69.

Several other equities analysts have also commented on PAHC. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, Phibro Animal Health currently has an average rating of “Hold” and an average price target of $21.00.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC increased its holdings in shares of Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after purchasing an additional 27,201 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Phibro Animal Health by 8.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 290,656 shares of the company’s stock valued at $6,104,000 after buying an additional 22,263 shares during the period. Bank of New York Mellon Corp raised its position in shares of Phibro Animal Health by 2.9% during the 4th quarter. Bank of New York Mellon Corp now owns 272,632 shares of the company’s stock worth $5,725,000 after buying an additional 7,747 shares in the last quarter. Globeflex Capital L P lifted its stake in shares of Phibro Animal Health by 0.8% in the 4th quarter. Globeflex Capital L P now owns 206,595 shares of the company’s stock worth $4,338,000 after acquiring an additional 1,700 shares during the period. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in shares of Phibro Animal Health by 116.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock valued at $4,330,000 after acquiring an additional 103,491 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Stock Up 10.7 %

The firm has a market cap of $1.06 billion, a price-to-earnings ratio of 54.63, a price-to-earnings-growth ratio of 0.53 and a beta of 0.52. The stock’s 50 day moving average is $21.90 and its 200 day moving average is $21.70. The company has a quick ratio of 1.69, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Analysts forecast that Phibro Animal Health Co. will post 1.94 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.